Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Tax Provisions (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Tax Provisions for 16 consecutive years, with $8.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Tax Provisions rose 5.69% to $8.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $30.2 million, a 20.86% decrease, with the full-year FY2024 number at $34.3 million, down 11.31% from a year prior.
  • Tax Provisions was $8.5 million for Q3 2025 at Usana Health Sciences, up from $8.4 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $16.1 million in Q3 2021 to a low of $5.9 million in Q4 2024.
  • A 5-year average of $10.1 million and a median of $9.8 million in 2023 define the central range for Tax Provisions.
  • Peak YoY movement for Tax Provisions: skyrocketed 33.94% in 2021, then plummeted 39.61% in 2024.
  • Usana Health Sciences' Tax Provisions stood at $16.1 million in 2021, then crashed by 37.75% to $10.0 million in 2022, then fell by 1.62% to $9.8 million in 2023, then tumbled by 39.61% to $5.9 million in 2024, then soared by 42.24% to $8.5 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Tax Provisions are $8.5 million (Q3 2025), $8.4 million (Q2 2025), and $7.4 million (Q1 2025).